Otsuka Canada Pharmaceutical Inc.

Clinical trials sponsored by Otsuka Canada Pharmaceutical Inc., explained in plain language.

Now part of Otsuka Holdings Co., Ltd. 4578 TOKYO

Canadian subsidiary of a Japanese pharmaceutical company focused on neuroscience, nephrology, and other therapeutic areas.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

530 canadians with kidney disease share real-world drug results

Knowledge-focused Completed

This study followed 530 adults with autosomal dominant polycystic kidney disease (ADPKD) who were already taking the drug tolvaptan (JINARC™). Researchers wanted to see how the medication affected their quality of life, pain, and daily activities, as well as how long it took befo…

Sponsor: Otsuka Canada Pharmaceutical Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:09 UTC

Otsuka Canada Pharmaceutical Inc.

530 canadians with kidney disease share real-world drug results